Literature DB >> 8106800

Progression and regression of coronary artery disease in one year. Quantitative angiographic assessment in patients with stable angina pectoris.

J Balkin1, M M Zion, D Rosenmann, M Ilan, M Klutstein, A S Abraham.   

Abstract

The rate of progression of coronary artery stenoses (CAS) is not clear. Spontaneous regression may also occur. Seventy-one CAS in 25 patients who were enrolled in a study of the effects of chromium on CAS were analysed. Coronary angiography was performed in multiple views and patients randomised to chromium or placebo treatment. Videodensitometric quantitative analysis was performed using a Vanguard XR70 Analyzer. After 1 year all patients were recatheterised. Corresponding frames from identical views were analysed. CAS were assessed with the observers blinded to the initial study results. No differences were found between chromium or placebo and the results have been combined. There was no overall progression of CAS as assessed by % area stenosis (p = 0.65), % diameter stenosis (p = 0.19), stenotic area (p = 0.87), or stenotic diameter (p = 0.99). However, 20% of individual lesions progressed, while 10% regressed, and 70% remained the same. These changes must be taken into account in studies of interventions which may modify the course of coronary atherosclerosis, and if coronary by-pass surgery is to be performed with a 1 year delay after angiography.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8106800     DOI: 10.1007/bf01145323

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  13 in total

1.  A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis.

Authors:  D Waters; J Lespérance; M Francetich; D Causey; P Théroux; Y K Chiang; G Hudon; L Lemarbre; M Reitman; M Joyal
Journal:  Circulation       Date:  1990-12       Impact factor: 29.690

2.  Reproducibility of measurements of coronary narrowings by videodensitometry: unreliability of single view measurements.

Authors:  J Balkin; D Rosenmann; M Ilan; M M Zion
Journal:  Int J Card Imaging       Date:  1990

3.  Variability of quantitative digital subtraction coronary angiography before and after percutaneous transluminal coronary angioplasty.

Authors:  M L Sanz; J Mancini; M T LeFree; J K Mickelson; M R Starling; R A Vogel; E J Topol
Journal:  Am J Cardiol       Date:  1987-07-01       Impact factor: 2.778

4.  Devolutionary pattern of coronary atherosclerosis in patients with angina pectoris. Coronary arteriographic studies.

Authors:  D Kimbiris; P Lavine; H Van Den Broek; M Najmi; W Likoff
Journal:  Am J Cardiol       Date:  1974-01       Impact factor: 2.778

5.  The anatomic evolution of coronary artery disease demonstrated by coronary arteriography in 256 nonoperated patients.

Authors:  A V Bruschke; T S Wijers; W Kolsters; J Landmann
Journal:  Circulation       Date:  1981-03       Impact factor: 29.690

6.  Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.

Authors:  G Brown; J J Albers; L D Fisher; S M Schaefer; J T Lin; C Kaplan; X Q Zhao; B D Bisson; V F Fitzpatrick; H T Dodge
Journal:  N Engl J Med       Date:  1990-11-08       Impact factor: 91.245

7.  Quantification of relative coronary arterial stenosis by cinevideodensitometric analysis of coronary arteriograms.

Authors:  A B Nichols; C F Gabrieli; J J Fenoglio; P D Esser
Journal:  Circulation       Date:  1984-03       Impact factor: 29.690

8.  Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.

Authors:  D H Blankenhorn; S A Nessim; R L Johnson; M E Sanmarco; S P Azen; L Cashin-Hemphill
Journal:  JAMA       Date:  1987-06-19       Impact factor: 56.272

9.  Progression of coronary atherosclerosis.

Authors:  J R Kramer; Y Matsuda; J C Mulligan; M Aronow; W L Proudfit
Journal:  Circulation       Date:  1981-03       Impact factor: 29.690

10.  Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators.

Authors:  P R Lichtlen; P G Hugenholtz; W Rafflenbeul; H Hecker; S Jost; J W Deckers
Journal:  Lancet       Date:  1990-05-12       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.